Puma Biotechnology (PBYI) Other Working Capital Changes (2012 - 2026)

Puma Biotechnology has reported Other Working Capital Changes for 15 years, with the latest figure at -$116000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes fell 1757.14% year-over-year to -$116000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 491.01% YoY), and the FY2025 full-year result was $1.2 million, up 85.82% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$116000.0, down from $26000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $5.1 million in Q4 2022, with the low at -$1.1 million in Q4 2023.
• Historically, Other Working Capital Changes has averaged $492616.8 across 5 years, with a median of $109185.0 in 2024.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes jumped 128650.0% — and 2026, when it tumbled 1757.14%.
• Puma Biotechnology's Other Working Capital Changes stood at $5.1 million in 2022, then sank by 120.93% to -$1.1 million in 2023, then surged by 245.07% to $1.6 million in 2024, then tumbled by 98.33% to $26000.0 in 2025, then plunged by 546.15% to -$116000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$116000.0 (Q1 2026), $26000.0 (Q4 2025), and $850176.0 (Q3 2025), per Business Quant data.